Feedback / Questions
spevatamig (PT886) - Phanes Therap
https://www.prnewswire.com/news-releases/phanes-therapeutics-to-present-phase-12-study-results-of-spevatamig-pt886-in-combination-with-chemotherapy-in-frontline-1l-treatment-of-metastatic-pdac-at-asco-gi-2026-302636991.html
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next